FDA approves an investigational new (oral) drug application that may allow people with celiac to consume gluten
Another (oral) therapeutic treatment for celiac disease is in the works!
The FDA approved an IND (investigational new drug) application from ActoBio for AG017, an oral biologic drug candidate.
Learn more here: https://www.biopharma-reporter.com/Article/2019/08/29/FDA-approves-IND-for-oral-biologic-to-treat-celiac-disease?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright
Read ActoBio’s Press Release here
